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Abstract
Background: His bundle (HB) potentials vary in amplitude and duration in patients with
and without slow pathways. The aim of this study was to determine the characteristics of
HB potentials and to elucidate whether they can provide clues for identification of slow 
pathway (SP). 
Methods: The present research prospectively studied the electrophysiological findings 
of 162 patients with symptomatic atrioventricular nodal reentrant tachycardia (AVNRT) 
due to slow-fast or fast-slow type and atrioventricular reentrant tachycardia (AVRT). 
Maximal HB potential (HBmax, HB with the highest amplitude) among HB cloud was 
recorded in both groups. For AVNRT patients, the following were measured: (1) AH 
interval at the “jump” during programmed atrial stimulation (A2H2, taken as a reflection
of SP conduction time); (2) Distance from HBmax to the successful SP ablation site 
(HBmax-ABL) and from HBmax to the ostium of coronary sinus (HBmax-CSO). 
Results: HBmax was 0.29 ± 0.10 mV in AVNRT patients, whereas it was 0.17 ± 0.05 
mV in AVRT group (p < 0.0001). Likewise, the HBmax duration was 22 ± 5 ms in 
AVNRT group and 16 ± 3 ms in AVRT group (p < 0.0001). The area under the ROC 
curve of HBmax amplitude in AVNRT patients was 0.86 and the optimal HBmax cut-off 
to predict AVNRT was ≥ 0.22 mV with a sensitivity of 0.78 and specificity of 0.84. 
HBmax-CSO was positively correlated with HBmax-ABL, and HBmax-ABL was 
positively correlated with A2H2. 
Conclusions: HBmax amplitudes were higher and durations longer in patients with 
AVNRT, as compared to those with AVRT. Moreover, the distance between HBmax and 
successful ablation site was positively correlated with the SP conduction time and with 
the distance from HBmax to the CS ostium. 
Key words: tachycardia, atrioventricular nodal reentry, slow pathway, His bundle, 
catheter ablation
Introduction
Since its introduction in 1992, catheter ablation of the slow pathway (SP) has 
been considered the first-line treatment in symptomatic patients with atrioventricular 
nodal reentrant tachycardia (AVNRT) [1]. The procedure is usually performed using 
fluoroscopy but three-dimensional mapping can provide further help by identifying the 
anatomical structures that are relevant for the ablation [2]. In some patients with AVNRT
it is also possible to record SP potentials in the perinodal region [3]. High-resolution 
mapping of the Triangle of Koch may increase the overall safety and efficacy of the 
ablation procedure [4]. 
The possibility to record His bundle (HB) potentials in humans was reported 
more than 5 decades ago [5]. In patients with atrioventricular (AV) conduction 
disturbances, the site of the block can be determined by recording the time delay 
between the HB signal and the earliest ventricular activation on surface 
electrocardiogram (ECG). The amplitude and duration of the HB signal depend on 
multiple factors, such as the type of catheter used, interelectrode spacing and orientation 
of the catheter tip. Despite widespread use of HB potentials in daily electrophysiology 
practice, detailed assessments of their signal characteristics in AVNRT patients are 
lacking. The aim of this study is to determine the distinctive features of the HB 
potentials, and elucidate if they provide clues for identification of patients with SP, an 
electrical prerequisite for the development of AVNRT.
Methods
Study patients 
Electrophysiological findings of consecutive patients with symptomatic AVNRT 
due to slow-fast type or fast-slow type reentry and AV reentrant tachycardia (AVRT) due
to an accessory pathway were studied between December 2018 to September 2020. The 
study data was prospectively collected in the Catheter Ablation Registry at the 
University Heart Center Zurich, which was approved by the Institutional Ethical 
Committee. 
Electrophysiological study findings
All electrophysiological studies were performed in the fasting, non-sedated state. 
After local anesthesia, multielectrode catheters were introduced percutaneously through 
the right femoral vein and positioned in high right atrial, right ventricular and HB 
positions, followed by measurements of basic electrophysiological parameters. AV nodal
effective refractory period (AVNERP) was measured at progressively shortening 
intervals following 8 drive trains at 600 ms. An atrio-His (AH) jump, suggestive of the 
presence of an SP, was identified, if there was a 50 ms or more increase in H1H2 interval
by using 10 ms decrements of A1A2. The longest conduction time of the fast pathway 
(A1H1) was measured as the last premature extrastimulus coupling interval before an 
AH jump. The shortest conduction time of the slow pathway (A2H2) was defined as the 
first premature extrastimulus coupling interval after an AH jump. All measurements 
were performed under baseline conditions without administration of isoprenaline. 
If a tachycardia was not inducible at baseline, isoproterenol was administered. 
Various stimulation techniques were used in both groups to ensure the induction and 
reproducibility of the clinical tachycardia. VAV response during ventricular entrainment 
was used to exclude an atrial tachycardia.
Mapping and catheter ablation 
After diagnosis of AVNRT or AVRT, a 7-Fr quadripolar, steerable radiofrequency
(RF) ablation catheter (Navistar 4 mm, Biosense Webster, Irvine, CA, USA) was 
introduced into the right atrium. Prior to mapping, calibration for respiratory 
compensation was performed. The filter settings for bipolar signals were set at the 16–
500 Hz range. Using the ablation catheter, anatomical locations showing HB potentials 
were extensively searched and tagged point-by-point using the CARTO 3-D 
electroanatomical mapping system (Biosense Webster, Irvine, CA, USA) to determine 
the His cloud (Fig. 1). For each patient, there was a minimum of 8 points that 
determined the His cloud. The HB signal with the maximal amplitude was labeled as 
HBmax. Every point was double-checked by offline analysis to confirm correct 
annotation. Three-dimensional mapping hallmarks of HBmax, the central point of the 
coronary sinus (CS) ostium, and the site of SP ablation (ABL) in the standard right 
anterior oblique view (RAO 30°) were annotated for distance identification. The 
amplitude and duration of HBmax between the two groups were measured using 
endocardial tracings at a recording speed of 400 mm/s. 
For SP ablation, the inferior/posterior aspect of the interatrial septum adjacent to 
the CS ostium was targeted. The local signal typically showed a small, low frequency 
atrial and a sizeable, high-frequency ventricular deflection, and rarely an SP potential, 
but no HB signal, as described by previous publications [6–8]. The ablation site was 
selected if there was adequate safety distance from the lowest HB point. The site of SP 
ablation (ABL, blue point in 3-D map) with best response showing slow junctional beats
during ablation was identified for each patient. AVRT patients were ablated along either 
the right or left AV valvular annulus, depending on the location of the accessory 
pathway. 
Radiofrequency energy was applied with an overall period of 60–120 s on the 
ablation site with a power setting in the range of 30–50 W for both groups. The endpoint
for AVNRT ablation was non-inducibility of the tachycardia. For patients with an AH 
jump (with or without an echo beat) after ablation, the SP ablation sites were often 
multiple. Since this study also aims at the SP ablation site, patients who had a residual 
SP were excluded from analysis. For AVRT patients, abolishing antegrade and/or 
retrograde accessory pathway conduction was considered as the endpoint of the 
procedure. Electrophysiologic study was repeated at least 20 min after last ablation to 
confirm the success of the procedure. In order to prevent thromboembolic complications,
intravenous heparin was administered during the procedure and subcutaneous 
unfractionated heparin was given post-operatively during bed rest. Patients who 
underwent ablation of left-sided accessory pathways were prescribed acetylsalicylic acid
for 4–6 weeks. All patients were discharged from the clinic either on the same day of the
procedure or on the day after. They were followed up at our cardiac arrhythmia clinic or 
by the referring physicians after discharge.
Statistical analysis
Data were expressed as means ± standard deviation. For continuous variables, 
data were expressed as median (interquartile range), and Kruskal–Wallis test was 
performed to examine the difference among groups. Mann–Whitney U test was used to 
test the difference in continuous variables between groups. The correlations between 
measurements were examined by linear regression analysis. For the HBmax 
measurements that significantly differed between AVNRT and AVRT groups, receiver 
operating characteristic (ROC) curve analysis was used to compare the predicted 
accuracy and determine cut-off values with optimal performance. Statistical significance
was set at p < 0.005.
Results
Patient characteristics
A total of 162 patients were finally enrolled in the study. Of these, 112 (57 ± 22 
years; 45 males) had AVNRT and the remaining 50 had AVRT (33 ± 12 years; 29 males).
No patients were enrolled in the latter group if they had evidence for the presence of 
concomitant dual AV nodal physiology. Eight patients had coronary artery disease (6 in 
AVNRT group). Four patients had sick sinus syndrome with an implanted pacemaker, 
one had dilated cardiomyopathy and one had valvular heart disease, all of whom in the 
AVNRT group. In the remaining 121 patients (74 AVNRT, 47 AVRT), there was no 
evidence of an underlying structural heart disease. All patients had normal systolic left 
ventricular function (left ventricular ejection fraction [LVEF] > 50%), except for one 
AVNRT patient with cardiomyopathy having an LVEF of 36%. All antiarrhythmic drugs 
were discontinued prior to electrophysiological study latest on the previous day prior to 
the procedure. In the AVNRT group, 5 fast-slow type AVNRTs were identified and 107 
slow-fast AVNRTs were diagnosed prior to ablation. In the AVRT group, 12 WPW 
patients were found to have pre-excited electrocardiogram at baseline. For concealed 
accessory pathways, 16 patients demonstrated anterograde concealment, 16 
demonstrated retrograde concealment, and 6 demonstrated both anterograde and 
retrograde concealment. Regarding the localization of the accessory pathways around 
the mitral and tricuspid annuli, there were 6 accessory pathways in the right anterior 
septum, 4 in the right mid-septum, 9 in the right posterior septum, 10 in the right sided 
free wall (4 right posterior or right posterolateral, 3 right lateral, 3 right anterior), 4 in 
the left posterior septum, 1 in the left mid-septum, 16 in the left lateral free wall (13 left 
lateral or left anterolateral, 3 left posterior or left posterolateral). 
The catheter ablation procedure was acutely successful and uneventful in all 
patients in both AVNRT and AVRT cohorts. Twelve-lead surface electrocardiography 
parameters and electrophysiological measurements prior to and after ablation in patients 
of both groups were shown in Table 1. 
HB potential characteristics in AVNRT patients compared with AVRT patients
There were significant differences in HBmax amplitude and duration between the
AVNRT (slow-fast and fast-slow type) and AVRT groups after adjusting for age and 
gender, as shown in Figure 2. The HBmax amplitude was 0.29 ± 0.10 mV in AVNRT 
patients, whereas it was 0.17 ± 0.05 mV in the AVRT group (p < 0.0001). Likewise, the 
HBmax duration was 22 ± 5 ms in the AVNRT group and 16 ± 3 ms in the AVRT group 
(p < 0.0001). Moreover, in five AVNRT patients with fast-slow type reentry, HBmax 
amplitude was 0.36 ± 0.09 mV and duration was 24 ± 2.8 ms, which were significantly 
different than those values in AVRT patients (p < 0.0001).
It was then sought to define the diagnostic value of HBmax amplitude and 
duration for discrimination of AVNRT due to SP from AVRT. After adjusting for age and
gender, linear logistic regression analysis revealed that HBmax amplitude and duration 
were independent predictors for AVNRT (Fig. 3). The area under the ROC curve (AUC) 
of HBmax amplitude in AVNRT patients was 0.86, and the optimal cut-off to predict 
AVNRT was equal to or greater than 0.22 mV with a sensitivity of 0.78 and specificity 
of 0.84 (Fig. 2). Meanwhile, the AUC of HBmax duration was 0.69, and the optimal cut-
off to predict AVNRT was equal to or greater than 20 ms with a sensitivity of 0.49 and 
specificity of 0.83.
Electrophysiological and anatomical correlations of HBmax in AVNRT patients
Three-dimensional CARTO maps showed 15.4 ± 4.9 mm distance 
between the successful ablation site and the HBmax recording site. The distance 
between the center of the CS ostium and the HBmax recordings site was 23.5 ± 5.6 mm. 
The mean A2H2 interval with an SP conduction was 250 ± 48 ms. The distance between 
HBmax and CS ostium was positively correlated with the distance between HBmax and 
the successful ablation site (r2 = 0.7174, 95% confidence interval [CI] 0.6101 to 0.7989, 
p = 0.0004), in accordance with the previous publication (Fig. 4) [9]. The HBmax 
distance from the successful ablation site was positively correlated with the shortest SP 
conduction time (A2H2) (r2 = 0.3368, 95% CI 0.1515 to 0.4993, p < 0.00001), but it was
not correlated with HBmax amplitude or duration. The distance between HBmax and CS
ostium was not correlated with A2H2. Likewise, it was neither correlated with HBmax 
amplitude nor HBmax duration.
Ablation procedure and follow up 
 Ablation was successfully performed in all patients enrolled. No significant 
cardiac adverse effects occurred during energy application, and all had preserved AV 
conduction. The overall duration of each study was 1–3 hours. No patient had 
tachycardia recurrence or apparent electrocardiography parameter changes with a mean 
post-ablation period of 6 months. 
Discussion
Main findings
The present study had several findings: First, it was demonstrated that HBmax 
amplitudes were higher and HBmax durations were longer in patients with AVNRT, as 
compared to those measurements in patients with AVRT. These measurements might be 
helpful for primary evaluation of the two arrhythmic conditions with a relatively high 
sensitivity and specificity. Second, the distance between HBmax and successful ablation 
site was positively correlated with the SP conduction time and with the distance from 
HBmax to the CS ostium. These findings may be helpful in choosing the optimal SP site 
for ablation.
The higher HBmax amplitudes and longer HBmax durations were not only 
observed in patients with typical AVNRT but were also observed in patients with 
atypical AVNRT due to fast-slow type reentry, as compared to those measured in patients
with AVRT. On the other hand, these measurements were not significantly different in 
patients with left-sided, right-sided, or septal accessory pathways. The differential 
diagnosis of atypical AVNRT from AVRT could be challenging since extra 
electrophysiologic maneuvers were often required, such as parahisian pacing and 
ventricular entrainment [10, 11]. The HBmax measurements might provide primary 
clues for dual AVN physiology and lead to corresponding electrophysiological study 
protocol priority for mechanism identification.
Distinctive His bundle potential in AVNRT patients
It has been known for more than 30 years that longitudinal dissociation within 
the posterior AV nodal region is the main mechanism, which gives rise to localized 
reentry and AVNRT [12]. Despite this, the signal characteristics of the HB potentials in 
human beings with an SP have not been scrutinized in depth to date. Only previous 
observations from rabbit AVNRT models show an augmentation of the HB signal 
amplitude during pacing with short premature coupling intervals [13]. The current study,
using electroanatomical 3D mapping of the AV nodal and HB region, fills the knowledge
gap for patients with AVNRT and is in line with previous observations from animal 
models. In the present study, particular attention was paid to obtaining a complete 
representation of the His bundle cloud by taking eight or more annotation points along 
the area of His bundle that showed distinct HB potentials. The observed augmentation of
the HBmax signal (especially its amplitude) in patients with AVNRT possibly reflects an 
electrical region that represents the continuation of two distinct electrical pathways 
joining together into an enhanced HB deflection. Clearly, this also necessitates proper 
orientation of the fibers at the bipolar recording site of the His catheter. This illustration 
is shown in the form of a schematic diagram in Figure 5. 
The presence of an SP may also be manifested in some occasions during sinus 
rhythm. Intermittent occurrence of prolonged PR intervals, which may arise following 
ectopic beats, may suggest an SP [14]. Ablative elimination of the SP in such patients 
will restore physiological AV conduction over the fast pathway. Moreover, dual AV 
nodal non-re-entrant tachycardia, which is characterized by double antegrade conduction
from a single sinus nodal activity simultaneously via the slow and fast AV nodal 
pathways into the ventricle, has been described [15, 16]. Furthermore, SP potentials 
prior to the HB deflection can also be detected by electrophysiological catheter during 
sinus rhythm on some occasions [3]. 
Meanwhile, immunobiological study on human AV junction demonstrates 
differential Cx43(+) myocyte distribution, with rightward nodal extensions and HB 
much more than leftward nodal extensions and compact node (Fig. 5) [17]. These 
observations provide further proof of the unique conduction properties of different parts 
of AV junctional area, which contribute to longitudinal dissociation and reentrant 
arrhythmias.
HBmax electrophysiology correlates with related anatomy in AVNRT patients
The positive correlation between SP conduction time and the distance from 
HBmax to successful ablation site, as observed in our study, may simply imply a longer 
conduction time for the SP wavefront to perpetuate due to a longer anatomical distance. 
This finding is in line with the findings of Dagres et al. [18] who demonstrated that SP 
with longer conduction intervals was more often ablated in a more inferior area of the 
Koch’s triangle. 
The observed difference in tachycardia cycle length between AVNRT and AVRT 
in the current study is in line with previous observations in adult patients [19]. In 
contrast, tachycardia cycle length of the two arrhythmic conditions does not differ in 
pediatric patients [20]. This discrepancy is explained as the conduction of both fast and 
slow pathways is faster in children than in adults. The adult patients in the study herein, 
did not manifest a correlation between age and SP conduction time or the distance from 
HBmax to CS ostium. 
Limitations of the study
The present study has some limitations. HBmax in this study was observed 
during sinus rhythm before any electrophysiological maneuvers or medication induction 
was introduced. This could only give us a preliminary assessment of possible differential
diagnosis of dual AVN physiology or AVNRT. Whereas the fundamental evaluation and 
step-by-step electrophysiological study can never be underestimated. Moreover, since 
the focus herein was on the effective ablation site compared to other anatomical 
structures within the Triangle of Koch, patients with multiple SPs were excluded. 
Therefore, we could not comment on whether observations would hold true in patients 
with slow-slow type reentry. 
Conclusions
HBmax amplitudes are higher and HBmax durations are longer in patients with 
AVNRT, as compared to those in AVRT. These features may provide preliminary clues to
differentiate the two arrhythmic conditions with relatively high sensitivity and 
specificity. Moreover, the distance between HBmax and successful ablation site is 
positively correlated with the SP conduction time and with the distance from HBmax to 
the CS ostium. These findings are helpful in determining the presence of an SP and in 
optimizing SP ablation.
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Table 1. Electrophysiologic parameters in AVNRT and AVRT patients.
AVNRT AVRT P
N N = 112, 45 male N = 50, 29 male < 0.005*
Age [years] 57 ± 22 33 ± 12 > 0.005*
Parameters Prior ablation Post ablation Prior ablation Post ablation  








A1H1 interval [ms] 159 ± 38 NA NA NA
A2H2 interval [ms] 250 ± 48 (n = 107)@ NA NA NA
HV interval [ms] 45 ± 6 45 ± 5 NA 43 ± 4
< 0.005*
< 0.005#
Tachycardia CL [ms] 388 ± 58 NA 372 ± 65 NA < 0.005*
Data were presented as median (lower to upper quartile; range) or mean ± standard deviation. AVNRT — 
atrioventricular nodal reentrant tachycardia; AVRT — atrioventricular reentrant tachycardia; AVBCL — 
atrioventricular block cycle length; VABCL — ventriculoatrial block cycle length; A1H1 — fast pathway 
conduction time; A2H2 — slow pathway conduction time; HV — conduction time from His Bundle to 
earliest ventricular activation on surface electrocardiogram; CL — cycle length; NA — no relevant 
measurement available; *Compared between AVNRT and AVRT groups prior or post-ablation; #Compared 
within group prior or post-ablation; 1#In AVNRT group; 2#In AVRT group; @Note that the Pearson 
correlation analysis related to A2H2 was performed in 107 typical AVNRT patients, excluding 5 patients 
fast-slow type AVNRT who had no observed antegrade slow pathway conduction
Figure 1. Anatomical hallmarks (His cloud, coronary sinus and ablation points) are 
shown on a CARTO 3-D electroanatomical map in (A) right anterior oblique (RAO, 30°)
and (B) left anterior oblique (LAO, 60°) views and endocardial electrograms with a 
recording speed of 400 mm/s are shown in (C). HB — bundle of His; HBmax — 
maximal His potential; CSO — ostium of coronary sinus; ABL — ablation site. The 
maximal HB potential (HBmax) was marked as a green point within the His cloud 
(multiple yellow points). The best site with induction of slow junctional beats among 
various ablation points (in red) was labeled as ABL (blue point). The center of coronary 
sinus ostium was also marked (white point). The red arrow line indicates the distance 
between HBmax and coronary sinus ostium. The green arrow line indicates the distance 
between HBmax and the slow pathway ablation site. Due to coronary sinus ostium 
variability, its center was determined as the intersection of the longest diameter and the 
shortest diameter. 
Figure 2. Scatterplot of cut-off values of maximal His potential (HBmax) amplitude (A) 
and HBmax duration (B) in AVNRT patients; AVNRT — atrioventricular nodal reentrant
tachycardia; AVRT — atrioventricular reentrant tachycardia.
Figure 3. Receiver operating characteristic (ROC) curve analysis for the optimal cut-off 
values of maximal His potential (HBmax) amplitude (A) and HBmax duration (B).
Figure 4. Pearson correlations between the distance maximal His potential (HBmax) site
from the successful ablation site and coronary sinus ostium (CSO) (A), and the distance 
HBmax site from the successful ablation site and slow pathway conduction (A2H2) (B); 
ABL — ablation site.
Figure 5. Schematic illustration of dual pathway anterograde conduction. The schematic
represents the Koch’s triangle and adjacent area; A. Triangle of Koch in the RAO 
projection and the location of HBmax and ABL hallmarks; B. Fast pathway conduction 
of sinus activity to distal HB in patients without dual atrioventricular conduction; C. The
dual pathway conduction of sinus activity to distal HB through longitudinal dissociation 
in patients with atrioventricular nodal reentrant tachycardia. The red arrows represent 
fast pathway conduction, and the blue curved arrows represent slow pathway 
conduction. The yellow area represents Cx 43(–) cells, and the green area the Cx 43(+) 
cells. TT — tendon of Todaro; TV — tricuspid valve; CSO — ostium of coronary sinus; 
ABL — successful ablation site; HB — His bundle; HBmax — maximal His bundle 
recording site; FP — fast pathway; SP — slow pathway.
